CD274 and cancer: Based on initial pilot findings that GEM treatment upregulates PD‐L1 expression in cancer cells, the chemotherapeutic agent GEM and αPD‐L1 were rationally engineered in a single scaffold to enhance cellular uptake and intratumor delivery as well as activate CTLs.